Zobrazeno 1 - 10 of 300 pro vyhledávání: '"Fukihara J"'
1
Akademický článek
Responsiveness and minimal clinically important difference of the COPD Assessment Test in fibrotic interstitial lung disease.
Autor: Matsuda T; Department of Respiratory Medicine and Allergy, Tosei General Hospital, 489-8642, 160 Nishioiwake-cho, Seto City, Aichi, Japan., Kondoh Y; Department of Respiratory Medicine and Allergy, Tosei General Hospital, 489-8642, 160 Nishioiwake-cho, Seto City, Aichi, Japan. Electronic address: konyasu2003@yahoo.co.jp., Takei R; Department of Respiratory Medicine and Allergy, Tosei General Hospital, 489-8642, 160 Nishioiwake-cho, Seto City, Aichi, Japan., Sasano H; Department of Respiratory Medicine and Allergy, Tosei General Hospital, 489-8642, 160 Nishioiwake-cho, Seto City, Aichi, Japan., Fukihara J; Department of Respiratory Medicine and Allergy, Tosei General Hospital, 489-8642, 160 Nishioiwake-cho, Seto City, Aichi, Japan., Yamano Y; Department of Respiratory Medicine and Allergy, Tosei General Hospital, 489-8642, 160 Nishioiwake-cho, Seto City, Aichi, Japan., Yokoyama T; Department of Respiratory Medicine and Allergy, Tosei General Hospital, 489-8642, 160 Nishioiwake-cho, Seto City, Aichi, Japan., Kataoka K; Department of Respiratory Medicine and Allergy, Tosei General Hospital, 489-8642, 160 Nishioiwake-cho, Seto City, Aichi, Japan., Watanabe F; Department of Rehabilitation, Tosei General Hospital, 160 Nishioiwake-cho, Seto City, Aichi, Japan., Kimura T; Department of Respiratory Medicine and Allergy, Tosei General Hospital, 489-8642, 160 Nishioiwake-cho, Seto City, Aichi, Japan.
Publikováno v: Respiratory investigation [Respir Investig] 2024 Nov; Vol. 62 (6), pp. 1088-1093. Date of Electronic Publication: 2024 Sep 26.
Zobrazit plný text záznamu
2
Report
Idiopathic Pulmonary Fibrosis Incidentally Detected by Computed Tomography Scan as Interstitial Lung Abnormalities.
Autor: Bando T; Tosei General Hospital Seto, Japan., Takei R; Tosei General Hospital Seto, Japan., Fukihara J; Tosei General Hospital Seto, Japan., Sasano H; Tosei General Hospital Seto, Japan., Yamano Y; Tosei General Hospital Seto, Japan., Yokoyama T; Tosei General Hospital Seto, Japan., Matsuda T; Tosei General Hospital Seto, Japan., Kataoka K; Tosei General Hospital Seto, Japan., Kimura T; Tosei General Hospital Seto, Japan., Fukuoka J; Nagasaki University Graduate School of Biomedical Sciences Nagasaki, Japan.; Kameda Medical Center Kamogawa, Japan., Hatabu H; Brigham and Women's Hospital Boston, Massachusetts., Johkoh T; Kansai Rosai Hospital Amagasaki, Japan., Kondoh Y; Tosei General Hospital Seto, Japan.
Publikováno v: Annals of the American Thoracic Society [Ann Am Thorac Soc] 2024 Jun; Vol. 21 (6), pp. 983-985.
Zobrazit plný text záznamu
3
Akademický článek
Mitochondrial DNA in bronchoalveolar lavage fluid is associated with the prognosis of idiopathic pulmonary fibrosis: a single cohort study.
Autor: Fukihara J; Department of Respiratory Medicine and Allergy, Tosei General Hospital, Seto, Aichi, Japan.; Department of Respiratory Medicine, Nagoya University Graduate School of Medicine, 65 Tsurumai-Cho, Showa-Ku, Nagoya, Aichi, Japan., Sakamoto K; Department of Respiratory Medicine, Nagoya University Graduate School of Medicine, 65 Tsurumai-Cho, Showa-Ku, Nagoya, Aichi, Japan. sakakoji@med.nagoya-u.ac.jp., Ikeyama Y; Department of Respiratory Medicine, Nagoya University Graduate School of Medicine, 65 Tsurumai-Cho, Showa-Ku, Nagoya, Aichi, Japan., Furukawa T; Medical IT Center, Nagoya University Hospital, Nagoya, Aichi, Japan., Teramachi R; Department of Respiratory Medicine, Nagoya University Graduate School of Medicine, 65 Tsurumai-Cho, Showa-Ku, Nagoya, Aichi, Japan., Kataoka K; Department of Respiratory Medicine and Allergy, Tosei General Hospital, Seto, Aichi, Japan., Kondoh Y; Department of Respiratory Medicine and Allergy, Tosei General Hospital, Seto, Aichi, Japan., Hashimoto N; Department of Respiratory Medicine, Fujita Health University School of Medicine, Toyoake, Aichi, Japan., Ishii M; Department of Respiratory Medicine, Nagoya University Graduate School of Medicine, 65 Tsurumai-Cho, Showa-Ku, Nagoya, Aichi, Japan.
Publikováno v: Respiratory research [Respir Res] 2024 May 10; Vol. 25 (1), pp. 202. Date of Electronic Publication: 2024 May 10.
Zobrazit plný text záznamu
4
Akademický článek
Mild elevation of pulmonary vascular resistance predicts mortality regardless of mean pulmonary artery pressure in mild interstitial lung disease.
Autor: Sato T; Department of Respiratory Medicine, Nagoya University Graduate School of Medicine, Nagoya, Japan., Furukawa T; Department of Respiratory Medicine, Nagoya University Graduate School of Medicine, Nagoya, Japan.; Medical IT Center, Nagoya University Hospital, Nagoya, Japan., Teramachi R; Department of Respiratory Medicine, Nagoya University Graduate School of Medicine, Nagoya, Japan.; Medical IT Center, Nagoya University Hospital, Nagoya, Japan., Fukihara J; Department of Respiratory Medicine and Allergy, Tosei General Hospital, Seto, Japan., Yamano Y; Department of Respiratory Medicine and Allergy, Tosei General Hospital, Seto, Japan., Yokoyama T; Department of Respiratory Medicine and Allergy, Tosei General Hospital, Seto, Japan., Matsuda T; Department of Respiratory Medicine and Allergy, Tosei General Hospital, Seto, Japan., Kataoka K; Department of Respiratory Medicine and Allergy, Tosei General Hospital, Seto, Japan., Kimura T; Department of Respiratory Medicine and Allergy, Tosei General Hospital, Seto, Japan., Sakamoto K; Department of Respiratory Medicine, Nagoya University Graduate School of Medicine, Nagoya, Japan., Ishii M; Department of Respiratory Medicine, Nagoya University Graduate School of Medicine, Nagoya, Japan., Kondoh Y; Department of Respiratory Medicine and Allergy, Tosei General Hospital, Seto, Japan kondoh@tosei.or.jp.
Publikováno v: Thorax [Thorax] 2024 Apr 15; Vol. 79 (5), pp. 422-429. Date of Electronic Publication: 2024 Apr 15.
Zobrazit plný text záznamu
5
Akademický článek
Effectiveness of remdesivir-based therapy for moderate COVID-19: comparison of Omicron and other variant phases.
Autor: Suzuki A; Department of Respiratory Medicine, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan.; Department of Internal Medicine, Aichi Prefectural Hospital, Okazaki, Aichi, Japan., Fukumitsu K; Department of Internal Medicine, Aichi Prefectural Hospital, Okazaki, Aichi, Japan.; Department of Respiratory Medicine, Allergy and Clinical Immunology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Aichi, Japan., Fukihara J; Department of Internal Medicine, Aichi Prefectural Hospital, Okazaki, Aichi, Japan.; Department of Respiratory Medicine and Allergy, Tosei General Hospital, Seto, Aichi, Japan., Katano T; Department of Internal Medicine, Aichi Prefectural Hospital, Okazaki, Aichi, Japan.; Department of Respiratory Medicine and Allergology, Aichi Medical University, Nagakute, Aichi, Japan., Kako H; Department of Internal Medicine, Aichi Prefectural Hospital, Okazaki, Aichi, Japan.; Department of Respiratory Medicine, Fujita Health University School of Medicine, Toyoake, Aichi, Japan., Maeda Y; Department of Internal Medicine, Aichi Prefectural Hospital, Okazaki, Aichi, Japan.; Department of Respiratory Medicine, Fujita Health University School of Medicine, Toyoake, Aichi, Japan., Ishii M; Department of Respiratory Medicine, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan., Niimi A; Department of Respiratory Medicine, Allergy and Clinical Immunology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Aichi, Japan., Imaizumi K; Department of Respiratory Medicine, Fujita Health University School of Medicine, Toyoake, Aichi, Japan., Yamaguchi E; Department of Internal Medicine, Aichi Prefectural Hospital, Okazaki, Aichi, Japan.; Department of Respiratory Medicine and Allergology, Aichi Medical University, Nagakute, Aichi, Japan.
Publikováno v: Journal of chemotherapy (Florence, Italy) [J Chemother] 2024 Apr; Vol. 36 (2), pp. 127-132. Date of Electronic Publication: 2023 Dec 03.
Zobrazit plný text záznamu
6
Akademický článek
Disease progression and changes in KL-6 in patients with limited cutaneous systemic sclerosis-associated interstitial lung disease.
Autor: Takei R; Department of Respiratory Medicine and Allergy, Tosei General Hospital, Seto, Japan., Yamano Y; Department of Respiratory Medicine and Allergy, Tosei General Hospital, Seto, Japan., Kataoka K; Department of Respiratory Medicine and Allergy, Tosei General Hospital, Seto, Japan., Fukihara J; Department of Respiratory Medicine and Allergy, Tosei General Hospital, Seto, Japan., Sasano H; Department of Respiratory Medicine and Allergy, Tosei General Hospital, Seto, Japan., Yokoyama T; Department of Respiratory Medicine and Allergy, Tosei General Hospital, Seto, Japan., Matsuda T; Department of Respiratory Medicine and Allergy, Tosei General Hospital, Seto, Japan., Kimura T; Department of Respiratory Medicine and Allergy, Tosei General Hospital, Seto, Japan., Kondoh Y; Department of Respiratory Medicine and Allergy, Tosei General Hospital, Seto, Japan. Electronic address: kondoh@tosei.or.jp.
Publikováno v: Respiratory investigation [Respir Investig] 2024 Jan; Vol. 62 (1), pp. 44-48. Date of Electronic Publication: 2023 Nov 07.
Zobrazit plný text záznamu
7
Akademický článek
COVID-19 and interstitial lung diseases: A multifaceted look at the relationship between the two diseases.
Autor: Fukihara J; Department of Respiratory Medicine and Allergy, Tosei General Hospital, 160 Nishioiwake-cho, Seto, Aichi, 489-8642, Japan., Kondoh Y; Department of Respiratory Medicine and Allergy, Tosei General Hospital, 160 Nishioiwake-cho, Seto, Aichi, 489-8642, Japan. Electronic address: kondoh@tosei.or.jp.
Publikováno v: Respiratory investigation [Respir Investig] 2023 Sep; Vol. 61 (5), pp. 601-617. Date of Electronic Publication: 2023 Jun 20.
Zobrazit plný text záznamu
8
Akademický článek
Changes in patient-reported outcomes in patients with non-idiopathic pulmonary fibrosis fibrotic interstitial lung disease and progressive pulmonary fibrosis.
Autor: Takei R; Department of Respiratory Medicine and Allergy, Tosei General Hospital, Seto, Japan., Matsuda T; Department of Respiratory Medicine and Allergy, Tosei General Hospital, Seto, Japan., Fukihara J; Department of Respiratory Medicine and Allergy, Tosei General Hospital, Seto, Japan., Sasano H; Department of Respiratory Medicine and Allergy, Tosei General Hospital, Seto, Japan., Yamano Y; Department of Respiratory Medicine and Allergy, Tosei General Hospital, Seto, Japan., Yokoyama T; Department of Respiratory Medicine and Allergy, Tosei General Hospital, Seto, Japan., Kataoka K; Department of Respiratory Medicine and Allergy, Tosei General Hospital, Seto, Japan., Kimura T; Department of Respiratory Medicine and Allergy, Tosei General Hospital, Seto, Japan., Suzuki A; Department of Respiratory Medicine, Nagoya University Graduate School of Medicine, Nagoya, Japan., Furukawa T; Department of Respiratory Medicine, Nagoya University Graduate School of Medicine, Nagoya, Japan.; Medical IT Center, Nagoya University Hospital, Nagoya, Japan., Fukuoka J; Department of Pathology, Nagasaki University Hospital, Nagasaki, Japan., Johkoh T; Department of Radiology, Kansai Rosai Hospital, Amagasaki, Japan., Kondoh Y; Department of Respiratory Medicine and Allergy, Tosei General Hospital, Seto, Japan.
Publikováno v: Frontiers in medicine [Front Med (Lausanne)] 2023 Jun 30; Vol. 10, pp. 1067149. Date of Electronic Publication: 2023 Jun 30 (Print Publication: 2023).
Zobrazit plný text záznamu
9
Akademický článek
Real-World Experience of the Comparative Effectiveness and Safety of Molnupiravir and Nirmatrelvir/Ritonavir in High-Risk Patients with COVID-19 in a Community Setting.
Autor: Mutoh Y; Department of Infectious Diseases, Tosei General Hospital, Seto 489-8642, Japan., Umemura T; Department of Infection Control Team, Tosei General Hospital, Seto 489-8642, Japan., Nishikawa T; Department of Infectious Diseases, Tosei General Hospital, Seto 489-8642, Japan., Kondo K; Department of Respiratory Medicine and Allergy, Tosei General Hospital, Seto 489-8642, Japan., Nishina Y; Department of Respiratory Medicine and Allergy, Tosei General Hospital, Seto 489-8642, Japan., Soejima K; Department of Respiratory Medicine and Allergy, Tosei General Hospital, Seto 489-8642, Japan., Noguchi Y; Department of Respiratory Medicine and Allergy, Tosei General Hospital, Seto 489-8642, Japan., Bando T; Department of Respiratory Medicine and Allergy, Tosei General Hospital, Seto 489-8642, Japan., Ota S; Department of Respiratory Medicine and Allergy, Tosei General Hospital, Seto 489-8642, Japan., Shimahara T; Department of Respiratory Medicine and Allergy, Tosei General Hospital, Seto 489-8642, Japan., Hirota S; Department of Respiratory Medicine and Allergy, Tosei General Hospital, Seto 489-8642, Japan., Hagimoto S; Department of Respiratory Medicine and Allergy, Tosei General Hospital, Seto 489-8642, Japan., Takei R; Department of Respiratory Medicine and Allergy, Tosei General Hospital, Seto 489-8642, Japan., Fukihara J; Department of Respiratory Medicine and Allergy, Tosei General Hospital, Seto 489-8642, Japan., Sasano H; Department of Respiratory Medicine and Allergy, Tosei General Hospital, Seto 489-8642, Japan., Yamano Y; Department of Respiratory Medicine and Allergy, Tosei General Hospital, Seto 489-8642, Japan., Yokoyama T; Department of Respiratory Medicine and Allergy, Tosei General Hospital, Seto 489-8642, Japan., Kataoka K; Department of Respiratory Medicine and Allergy, Tosei General Hospital, Seto 489-8642, Japan., Matsuda T; Department of Respiratory Medicine and Allergy, Tosei General Hospital, Seto 489-8642, Japan., Kimura T; Department of Respiratory Medicine and Allergy, Tosei General Hospital, Seto 489-8642, Japan., Ichihara T; Department of Infectious Diseases, Tosei General Hospital, Seto 489-8642, Japan.; Department of Infection Control Team, Tosei General Hospital, Seto 489-8642, Japan., Kondoh Y; Department of Respiratory Medicine and Allergy, Tosei General Hospital, Seto 489-8642, Japan.
Publikováno v: Viruses [Viruses] 2023 Mar 22; Vol. 15 (3). Date of Electronic Publication: 2023 Mar 22.
Zobrazit plný text záznamu
10
Akademický článek
BMP3b Is a Novel Antifibrotic Molecule Regulated by Meflin in Lung Fibroblasts.
Autor: Suzuki A; Department of Respiratory Medicine and., Sakamoto K; Department of Respiratory Medicine and., Nakahara Y; Department of Respiratory Medicine and., Enomoto A; Department of Pathology, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan; and., Hino J; Department of Biochemistry, National Cerebral and Cardiovascular Center Research Institute, Suita, Osaka, Japan., Ando A; Department of Respiratory Medicine and., Inoue M; Department of Respiratory Medicine and., Shiraki Y; Department of Pathology, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan; and., Omote N; Department of Respiratory Medicine and., Kusaka M; Department of Respiratory Medicine and., Fukihara J; Department of Respiratory Medicine and., Hashimoto N; Department of Respiratory Medicine and.
Publikováno v: American journal of respiratory cell and molecular biology [Am J Respir Cell Mol Biol] 2022 Oct; Vol. 67 (4), pp. 446-458.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje